Eli Lilly | LLY - Ordinary Share Capital

Stock Price
1,005.53
Daily Change
-38.60 -3.70%
Monthly
-3.45%
Yearly
21.72%
Q1 Forecast
1,005.21

Eli Lilly reported $946.83M in Ordinary Share Capital for its fiscal quarter ending in June of 2025.





Ordinary Share Capital Change Date
AbbVie USD 1.77B 1.75B Jun/2025
Abbott USD 1.74B 23.39B Sep/2025
ALKERMES USD 165.1M 49K Sep/2025
Amgen USD 538M 300K Sep/2025
AstraZeneca USD 1.55B 1.16B Sep/2025
Baxter International USD 683M 0 Dec/2024
Biogen USD 146.7M 200K Sep/2025
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
Drreddys Laboratories INR 832.57M 53K Dec/2025
Eli Lilly USD 946.83M 354.23M Jun/2025
Gilead Sciences USD 1.24B 0 Sep/2025
GlaxoSmithKline GBP 4.03B 119.13M Sep/2025
Glaxosmithkline GBP 4.03B 2.68B Sep/2025
J&J USD 2.41B 584K Sep/2025
Medtronic USD 1.28B 66K Jun/2025
Merck USD 2.49B 15.79M Sep/2025
Neurocrine Biosciences USD 99.7M 700K Sep/2025
Novartis USD 1.94B 23.4M Jun/2025
Novartis USD 1.92B 17.06M Sep/2025
Novo Nordisk DKK 4.44B 0 Sep/2025
Perrigo USD 137.6M 0 Sep/2025
Pfizer USD 5.69B 1000K Sep/2025
Prestige Brands USD 48.08M 47.52M Sep/2025
Regeneron Pharmaceuticals USD 105.3M 1.1M Sep/2025
Roche Holding CHF 795.62M 699.54K Dec/2025
United Therapeutics USD 42.9M 42.1M Sep/2025
Zoetis USD 441.46M 2.48M Sep/2025